Adaptin Bio APTN Growth Metrics (2023-2026)

OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT
Reported Financials

Adaptin Bio Quarterly Growth Metrics

Periods 14 quarters
Latest Jun 2026

Adaptin Bio growth metrics data for the quarter ended Jun 2026. These growth metrics cover 14 quarters of results from Mar 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Total Debt (QoQ) 60.44%0.00%88.47%19.23%734.84%-32.61%
Total Debt Growth (1y) 1,431.28%260.54%1,776.05%
Share-based Compensation (QoQ)Stock Comp. (QoQ) -123.43%560.53%-43.89%
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) 0.04M
Return on Assets [ROA] (QoQ)ROA (QoQ) -8.82M-24.12M-36.23M71.16M0.24M0.00M-0.02M-0.03M-0.02M0.02M
Return on Assets [ROA] Growth (1y)ROA Growth (1y) 1.99M11.05M35.17M71.39M0.20M-0.06M-0.05M
Operating Income (QoQ)Op. Inc (QoQ) 0.00%-910.31%20.46%-777.58%-156.00%-29.64%48.92%-67.39%-78.83%-10.18%18.36%16.36%-4.93%
Operating Income Growth (3y)Op. Inc Growth (3y) -545.70%-556.15%
Operating Income Growth (1y)Op. Inc Growth (1y) -6,952.61%-17,954.59%-2,216.71%-1,387.57%-183.74%-98.20%-68.45%-169.25%-34.53%21.06%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) 0.00%-910.31%20.46%-893.80%-141.21%-35.28%22.64%29.62%-152.18%-10.18%18.36%16.22%-5.17%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y) -546.07%-557.01%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) -7,886.64%-19,164.42%-2,479.42%-2,408.67%-77.67%-85.76%-51.29%-59.66%-90.04%20.75%
Net Income (QoQ) 0.00%0.00%-910.31%20.46%-893.80%-141.21%-35.28%22.64%29.62%-152.18%-10.18%18.36%16.22%-5.17%
Net Income Growth (3y) -585.33%-546.07%-557.01%
Net Income Growth (1y) -703.65%-7,886.64%-19,164.42%-2,479.42%-2,408.67%-77.67%-85.76%-51.29%-59.66%-90.04%20.75%
Net Cash Flow (QoQ)NCF (QoQ) 6,036.72%389.03%-188.74%2,981.13%-143.70%24.47%84.48%-31.65%333.86%
Net Cash Flow Growth (3y)NCF Growth (3y) -523.02%
Net Cash Flow Growth (1y)NCF Growth (1y) 767,160.33%-5,564.07%-943.89%-47.64%-106.75%136.10%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ) -106.51%40.33%62.69%-236.08%56.58%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y) -54.49%-4,930.93%
Income After Tax (QoQ) 0.00%-910.31%20.46%-893.80%-141.21%-35.28%22.64%29.62%-152.18%-10.18%16.42%18.16%-5.17%
Income After Tax Growth (3y) -546.07%-557.01%
Income After Tax Growth (1y) -7,886.64%-19,164.42%-2,479.42%-2,408.67%-77.67%-85.76%-51.29%-63.44%-90.04%20.75%
Free Cash Flow (QoQ)FCF (QoQ) -53.73%-127.24%-129.81%124.05%-2,123.80%55.14%24.47%9.00%15.16%24.51%
Free Cash Flow Growth (1y)FCF Growth (1y) 293.07%-2,441.81%-401.76%-64.90%-723.93%73.85%55.98%
EPS (Diluted) (QoQ) 0.00%-910.31%20.46%-893.80%-141.21%-35.28%22.64%39.60%-73.81%-10.16%11.63%24.79%-3.41%
EPS (Diluted) Growth (3y) -437.11%-443.16%
EPS (Diluted) Growth (1y) -7,886.64%-19,164.42%-2,479.42%-2,408.67%-52.46%-9.85%10.54%-2.19%-27.26%24.28%
EPS (Basic) (QoQ) 0.00%-910.31%20.46%-893.80%-141.21%-35.28%22.64%39.60%-73.81%-10.16%11.63%24.79%-3.41%
EPS (Basic) Growth (3y) -437.11%-443.16%
EPS (Basic) Growth (1y) -7,886.64%-19,164.42%-2,479.42%-2,408.67%-52.46%-9.85%10.54%-2.19%-27.26%24.28%
EBT (QoQ) 0.00%-910.31%20.46%-893.80%-141.21%-35.28%22.64%29.62%-152.18%-10.18%16.42%18.16%-5.17%
EBT Growth (3y) -546.07%-557.01%
EBT Growth (1y) -7,886.64%-19,164.42%-2,479.42%-2,408.67%-77.67%-85.76%-51.29%-63.44%-90.04%20.75%
EBIT (QoQ) 0.00%-910.31%20.46%-777.58%-156.00%-29.64%48.92%-67.39%-78.83%-10.18%18.36%16.36%-4.93%
EBIT Growth (3y) -545.70%-556.15%
EBIT Growth (1y) -6,952.61%-17,954.59%-2,216.71%-1,387.57%-183.74%-98.20%-68.45%-169.25%-34.53%21.06%
Cash from Operations (QoQ)Cash from Ops. (QoQ) -53.73%-127.24%-129.81%124.05%-2,123.80%55.14%24.47%9.00%15.16%24.51%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) 293.07%-2,441.81%-401.76%-64.90%-723.93%73.85%55.98%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) -24.00%1,151.05%6.42%369.97%-98.65%10,485.40%6,865.61%-43.08%-57.15%-20.71%-34.38%122.53%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y) 872.01%1,002.74%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) 850.80%4,655.20%-15.26%616.98%46,830.80%5,584.38%179,741.30%1,247.14%-87.31%-50.39%
Assets (QoQ) 0.00%0.00%-15.26%0.00%74,252.48%1,092.07%-41.74%-41.09%-36.79%14.04%38.99%
Assets Growth (3y) 973.85%
Assets Growth (1y) -24.00%-15.26%62,903.95%750,953.68%516,246.27%304,084.47%158.61%-75.26%-40.97%

Adaptin Bio Growth Metrics API

Pull Adaptin Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=APTN&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY